Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 759 record(s)

Req # A-2024-00002

Please provide all documents that set out "any conditions" that the CRTC's Chairperson has specified pursuant to section 11(1)(a.1) of the Online News Act.

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
May 2024

Req # A-2024-00004

From March 1, 2024 to April 24, 2024, any documents related to any oral communication between the CRTC and any external party requesting or encouraging that party to file an intervention or otherwise participate in the proceeding initiated by application 2024-0069-6 (Part 1 Application by David Lepofsky regarding Accessibility complaint related to TV services).

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
May 2024

Req # A-2023-001172

All decisions, including “No Objection” letters or equivalent, with respect to exemptions of “decocainized coca leaf extract” or “decocainized coca leaf extract” or “cocaine-free coca leaf extract” from the Controlled Drugs and Substances Act and its regulations. All policies and related materials related to exemptions of “de-cocainized coca leaf extract” or “decocainized coca leaf extract” or “cocaine-free coca leaf extract” from the Controlled Drugs and Substances Act and its regulations.

Organization: Health Canada

0 page(s)
May 2024

Req # A-2023-001433

All records between the federal government and the province of Albert relating to gender affirming care and puberty blockers for youth from August 10, 2023, to February 10, 2024.

Organization: Health Canada

0 page(s)
May 2024

Req # A-2023-001628

All communications originating from atrazine registrants, or their agents or representatives including the triazine network to the Pest Management Regulatory Agency (PMRA) regarding the aquatic reference values for atrazine and all PMRA internal emails and memoranda discussing those communications. Time period is January 1, 2023 to March 28, 2024.

Organization: Health Canada

0 page(s)
May 2024

Req # A-2024-000044

Documents and records containing information regarding the mock-ups of every label to be used in connection with the Fourth Desmopressin Abbreviated New Drug Submission (ANDS) and mock-ups of the drug product’s packages, as described in the Food and Drug Regulations.

Organization: Health Canada

0 page(s)
May 2024

Req # A-2024-000045

The most recent Module 2.3: Quality Overall Summary (QOS) submitted by the sponsor for the Fourth Desmopressin Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

0 page(s)
May 2024

Req # A-2024-000046

Any Canadian Reference Product Confirmation submitted by the sponsor of the Fourth Desmopressin Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

0 page(s)
May 2024

Req # A-2024-000050

If the Fourth Desmopressin Abbreviated New Drug Submission (ANDS) has received, a Screening Acceptance Letter, a Notice of Deficiency (NOD), a Notice of Non-Compliance (NON), a NOD-Withdrawal (NODW), a NON-Withdrawal (NON-W), provide the month and year that the notice was issued; and provide a copy of the correspondence.

Organization: Health Canada

0 page(s)
May 2024

Req # A-2024-000051

The Abbreviated New Drug Submission (ANDS) cover letter of the company who submitted the Fourth Desmopressin ANDS.

Organization: Health Canada

0 page(s)
May 2024
Date modified: